New markers of oxidant stress in chronic liver disease.

被引：0
|
作者：
Pemberton, P [1 ]
Jain, S [1 ]
Smith, A [1 ]
Warnes, TW [1 ]
机构：
[1] Manchester Royal Infirm, Liver Unit, Manchester M13 9WL, Lancs, England
来源：
GASTROENTEROLOGY | 1998年 / 114卷 / 04期
关键词：
D O I：
10.1016/S0016-5085(98)85361-4
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
L0503
引用
收藏
页码：A1321 / A1321
页数：1
相关论文
共 50 条
  • [21] von Willebrand factor in chronic liver disease.
    Kadayifci, A
    Simsek, H
    Tatar, G
    GASTROENTEROLOGY, 1997, 112 (04) : A1295 - A1295
  • [22] Heterotopic versus orthotopic liver transplantation for chronic liver disease.
    de Rave, S
    HEPATOLOGY, 1998, 28 (04) : 241A - 241A
  • [23] A new model for the origins of chronic disease.
    Barker D.J.
    Medicine, Health Care and Philosophy, 2001, 4 (1) : 31 - 35
  • [24] Chronic Kidney Disease - Chronic Liver Disease. An Immunologic Cross-talk
    Gluhovschi, Gh.
    Petrica, Ligia
    Timar, Sporea R.
    Curescu, Manuela
    Velciov, Silvia
    Gluhovschi, Cristina
    ROMANIAN JOURNAL OF INTERNAL MEDICINE, 2015, 53 (01) : 3 - 12
  • [25] Diagnostic value of fibrosis biochemical markers (FibroTest) for the screening of oesophageal varices in patients with chronic liver disease.
    Thabut, D
    Trabut, JB
    Le Calvez, S
    Thibaut, V
    Massard, J
    d'Arondel, C
    Moussalli, J
    Munteanu, M
    Imbert-Bismut, F
    Messous, D
    Benhamou, Y
    Ratziu, V
    Poynard, T
    HEPATOLOGY, 2003, 38 (04) : 293A - 293A
  • [26] Adherence to vaccination guidelines in patients with chronic liver disease.
    Arguedas, MR
    McGuire, BM
    Fallon, MB
    Abrams, GA
    Bloomer, JR
    HEPATOLOGY, 2000, 32 (04) : 314A - 314A
  • [27] Serum thrombopoietin and hepatosplenomegaly in patients with chronic liver disease.
    Satoi, J
    Sanjyou, Y
    Takekuma, A
    Nekohashi, T
    Abe, T
    Tsuboi, Y
    Suzuki, N
    Kato, T
    Tahara, T
    Tanaka, T
    HEPATOLOGY, 1997, 26 (04) : 309 - 309
  • [28] Pathophysiological and clinical role of erythropoietin in chronic liver disease.
    Tacke, F
    Schöffski, P
    Ganser, A
    Manns, MP
    Trautwein, C
    HEPATOLOGY, 2002, 36 (04) : 515A - 515A
  • [29] Ghrelin is a parameter of catabolism in patients with chronic liver disease.
    Tacke, F
    Brabant, G
    Kruck, E
    Horn, R
    Schöffski, P
    Manns, MP
    Trautwein, C
    HEPATOLOGY, 2002, 36 (04) : 530A - 530A
  • [30] Interaction of ursodeoxycholate with glycyrrhizin on the treatment of chronic liver disease.
    Mitsuyoshi, H
    Nakashima, T
    Inaba, K
    Sakamoto, Y
    Iwai, M
    Okanoue, T
    Kashima, K
    GASTROENTEROLOGY, 1996, 110 (04) : A1266 - A1266
12345